Advanced Medical Solutions Group Regulatory News (AMS)

4 Mar 2009 07:00



Advanced Medical Solutions Group plc 

("AMS" or "the Company")

Notification of Preliminary Results

Winsford, UK: Advanced Medical Solutions Group plc (AIM: AMS), the global medical technology company, will announce its preliminary results for the year ended 31 December 2008 on Tuesday 17 March 2009. 

A briefing for analysts will be held at 10am on the day of the results at the offices of Buchanan Communications, 45 Moorfields, London EC2Y 9AE.

-ENDS- 

For further information, please contact:

Notes to Editors:

Advanced Medical Solutions is a leading company in the development and manufacture of products for the $15 billion global woundcare market.

Founded in 1991 and quoted on AIM, Advanced Medical Solutions is focused on the design, development and manufacture of innovative and technologically advanced woundcare products.

In-house natural and synthetic polymer technology is used to provide advanced wound dressings based on the moist healing principle. AMS' resources ensure a unique position as a vertically integrated 'one stop shop' to provide all categories of moist wound healing products. The Company has the capability to move a product from design and development through to production and delivery for distribution and sale into customer markets.

The acquisition of 49.4% of Corpura BV in May 2008 strengthened AMS' position in hydrophilic polyurethane foam - the largest and fastest growing segment of the advanced woundcare market

AMS' technology in cyanoacrylate based tissue adhesives is used either for the closure of small cuts and trauma wounds through to large surgical incisions, or for protecting or sealing skin to prevent breakdown or infection. 

AMS' products currently serve the majority of the key global markets sold either direct or through strategic partners or distributors.